Ciliary neurotrophic factor selectively protects human oligodendrocytes from tumor necrosis factor-mediated injury

Journal of Neuroscience Research

Volumn 43, Issue 3, 1996, Pages 289-298

  D'Souza, S D ^a   Alinauskas, K A ^a   Antel, J P ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

apoptosis; ciliary neurotrophic factor; human oligodendrocytes; lysis; multiple sclerosis; tumor necrosis factor

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CD4 ANTIGEN; CHROMIUM 51; CILIARY NEUROTROPHIC FACTOR; CYTOKINE; NERVE GROWTH FACTOR; NEUROTROPHIC FACTOR; NEUROTROPHIN 3; NEUROTROPHIN 4; RECOMBINANT BETA INTERFERON; RECOMBINANT INTERLEUKIN 10; RECOMBINANT LYMPHOTOXIN; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; ARTICLE; AUTOIMMUNITY; CELL DAMAGE; CONTROLLED STUDY; CYTOTOXICITY; DEMYELINATING DISEASE; ETIOLOGY; FETUS; GLIOMA CELL; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; MULTIPLE SCLEROSIS; NERVE CELL CULTURE; OLIGODENDROGLIA; PRIORITY JOURNAL;

ADULT; ANTIBODIES; BRAIN; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; CELL SURVIVAL; CELLS, CULTURED; CILIARY NEUROTROPHIC FACTOR; CULTURE MEDIA; EPILEPSY; FETUS; GLIOMA; HUMANS; LYMPHOTOXIN-ALPHA; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; NEURONS; OLIGODENDROGLIA; RECOMBINANT PROTEINS; TEMPORAL LOBE; TIME FACTORS; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030062861     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19960201)43:3<289::AID-JNR4>3.0.CO;2-F     Document Type: Article

References (52)

1. + T cells independent of tumor necrosis factor. Ann Neurol 35:341-348.
2. Armstrong RC, Dorn HH, Kufta CV, Friedman E, Dubois-Dalcq M (1992): Pre-oligodendrocytes from adult human CNS. J Neurosci 12:1538-1547.
3. Barres BA, Hart IK, Coles HSR, Burne JF, Voyvodic JT, Richardson WD, Raff MC (1992): Cell death and control of cell survival in the oligodendrocyte lineage. Cell 70:31-46.
4. Barres BA, Raff MC, Gaese F, Bartke I, Dechant G, Barde YA (1994): A crucial role for Neurotrophin-3 in oligodendrocyte development. Nature 367:371-375.
5. Berke G (1994): The binding and lysis of target cells by cytotoxic lymphocytes: molecular and cellular aspects. Annu Rev Immunol 12:735-773.
6. Butt AM, Jenkins HG (1994): Morphological changes in oligodendrocytes in the intact mouse optic nerve following intravitreal injection of tumor necrosis factor. J Neuroimmunol 51:27-33.
7. Cogate N, Verma L, Zhou JM, Milwarad E, Rusten R, O'Connor M, Kufta C, Kim J, Hudson L, Dubois-Dalcq M (1994): Plasticity in the adult human oligodendrocyte lineage. J Neurosci 14: 4571-4587.
8. D'Souza S, Alinauskas KA, McRae E, Goodyear C, Antel JP (1995): Differential susceptibility of human CNS-denved cell populations to TNF-dependent and TNF-independent immune-mediated injury. J Neurosci 15(11):7293-7300.
9. Freedman MS, Ruijs TCG, Selin LK, Antel JP (1991): Peripheral blood γδ-T cells lyse fresh human brain-derived oligodendrocytes. Ann Neurol 30:794-800.
10. Grenier Y, Ruijs TCG, Robitaille Y, Olivier A, Antel JP (1989): Immunohistochemical studies of adult human glial cells. J Neuroimmunol 21:103-115.
11. Ip NY, Wiegand SJ, Morse J, Rudge JS (1993): Injury-induced regulation of ciliary neurotrophic factor messenger-RNA in the adult-rat brain. Eur J Neurosci 5:25-33.
12. Jenkins HG, Ikeda H (1992): Tumor necrosis factor causes an increase in axonal transport of protein and demyelination in the mouse optic nerve. J Neurol Sci 108:99-104.
13. Kahn MA, de Vellis J (1994): Regulation of an oligodendrocyte progenitor cell line by the interleukin-6 family of cytokines. Glia 12:87-98.
14. Kawai K, Zweiman B (1990): Characteristics of in vitro cytotoxic effects of myelin basic protein-reactive T cell lines on syngeneic oligodendrocytes. J Neuroimmunol 26:57-67.
15. Kennedy MK, Torrance DS, Picha KS, Mohler KM (1992): Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J Immunol 149:2496-2505.
16. Kim SU (1985): Antigen expression by glial cells grown in culture. J Neuroimmunol 8:255-282.
17. Kumar S, Pena LA, de Vellis J (1993): CNS glial cells express neurotrophin receptors whose levels are regulated by NGF. Brain Res Mol Brain Res 17:163-168.
18. Lee LN, Yokoyama M, Black IB, Dreyfus CF (1994): Neurotrophic regulation of oligodendrocyte development and function. Society Neurosci Abstr 20(1):693.
19. Lee SC, Raine CS (1989). Multiple Sclerosis: oligodendrocytes in active lesions do not express class II major histocompatibility complex molecules. J Neuroimmunol 25:261-266.
20. Loughlin AJ, Honnegar P, Woodroofe MN, Comte V, Matthieu JM, Cuzner ML (1994): Myelin basic protein content of aggregating rat brain cell cultures treated with cytokines and/or demyeli-nating antibody: effects of macrophage enrichment. J Neurosci Res 37:647-653.
21. Louis JC, Magal E, Takayama S, Varon S (1993): CNTF protection of oligodendrocytes against natural and tumor necrosis-induced death. Science 259:689-692.
22. MacLennan AJ, Gaskin AA, Lado DC (1994): CNTF receptor alpha mRNA expression in rodent cell lines and developing rat. Brain Res Mol Brain Res 25:251-256.
23. Magal E, Louis JC, Oudega M, Varon S (1993): CNTF promotes the survival of neonatal rat corticospinal neurons in vitro. J Neurochem 38:415-421.
24. Mayer M, Bhakoo K, Noble M (1994): CNTF and LIF promote generation, maturation and survival of oligodendrocytes in vitro. Development 120:143-153.
25. McKinnon RD, Piras G, Ida JA Jr, Dubois-Dalcq M (1993): A role for TGF-β in oligodendrocyte differentiation. J Cell Biol 121: 1307-1407.
26. McLarnon JG, Michikawa M, Kim SU (1993): Effects of TNF on inward potassium current and cell morphology in cultured human oligodendrocytes. Glia 9:120-126.
27. McLaurin J, Antel JP, Yong VW (1995a): Immune and non-immune actions of interferon β-1b on primary human neural cells. Multiple Sclerosis 1:10-19.
28. McLaurin J, D'Souza S, Stewart J, Blain M, Beaudet A, Nalbantoglu J, Antel JP (1995b): Effect of tumor necrosis factor α and β on human oligodendrocytes and neurons in culture. Int J Dev Res 13(3/4):369-381.
29. Merrill JE, Ignarro LJ, Sherman MP, Melinek J, Lane TE (1993): Microglial cell cytotoxicity for oligodendrocytes is mediated by nitric oxide. J Immunol 151:2132-2141.
30. Merrill JE, Zimmerman RP (1991): Natural and induced cytotoxicity of oligodendrocytes by microglia is inhibitable by TGF-β Glia 4:327-331.
31. Paty DW, Li DKB (1993): Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study group and the IFN-β multiple sclerosis study group. Neurology 43:662-667.
32. Prabhakar S, D'Souza S, Antel JP, McLaurin J, Schipper HM, Wang E (1995): Phenotypic and cell cycle properties of human oligodendrocytes in vitro. Brain Res 672:159-169.
33. Racke MK, Dhib-Jalbut S, Cannella B, Albert PA, Raine CS, McFarlin DE (1991): Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor β1. J Immunol 146:3012-3017.
34. Raff MC, Barres BA, Burne JF, Coles HS, Ishizaki Y, Jacobson MD (1993): Programmed cell death and the control of cell survival: lessons from the nervous system. Science 262:695-700.
35. Raine CS (1994): Multiple sclerosis: immune molecule expression in the central nervous system. J Neuropathol Exp Neurol 53:328-337.
36. Ranscht B, Clapshaw PA, Price J, Noble M, Seifert W (1982): Development of oligodendrocytes and Schwann cells studied with a monoclonal antibody against galactocerebroside. Proc Natl Acad Sci USA 79:2709-2713.
37. Ruddle NH, Bergman CM, McGarth KM, Lingenheld EG, Grunnet ML, Padula SJ, Clark RB (1990): An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J Exp Med 172:1193-1200.
38. Scolding NJ, Morgan BP, Houston A, Cambell AK, Linington C, Compston DA (1989): Normal rat serum cytotoxicity against syngeneic oligodendrocytes. Complement activation and attack in the absence of anti-myelin antibodies. J Neurol Sci 89:289-300.
39. Selmaj KW (1992): The role of cytokines in inflammatory conditions of the central nervous system. Semin Neurosci 4:221-229.
40. Selmaj KW, Raine CS (1988): Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 23:339-346.
41. Selmaj K, Raine CS, Cross AH (1991a): Anti-tumor necrosis factor therapy abrogates autoimmune demyelination. Ann Neurol 30: 694-700.
42. Selmaj K, Raine CS, Farooq M, Norton WT, Brosnan CF (1991b): Cytokine cytotoxicity against oligodendrocytes: Apoptosis induced by lymphotoxin. J Immunol 147:1522-1529.
43. Simmons ED, Willenborg DO (1990): Direct injection of cytokines into the spinal cord causes autoimmune encephalitis-like inflammation. J Neurol Sci 100:37-42.
44. Skaper SD, Negro A, DalToso R, Facci L (1992): Recombinant human ciliary neurotrophic factor alters the threshold of hippocampal pyramidal neuron sensitivity to excitotoxin damage: synergistic effects of monosialogangliosides. J Neurosci Res 33:330-337.
45. + current expression in cultured oligodendrocytes. J Membr Biol 124:127-137.
46. Vartanian TK, Li Y, Stefansson K (1994): Influence of cytokines on the fate of oligodendrocytes in vitro: implications for treatment of multiple sclerosis. Brain Pathol 4:494.
47. Willenborg DO, Fordham SA, Cowden WB, Kamshaw IA (1995): Cytokines and murine autoencephalomyelitis: inhibition or enhancement of disease with antibodies to select cytokines, or by delivery of exogenous cytokines using a recombinant vaccinia virus system. Scand J Immunol 41:31-41
48. Williams K, Dooley N, Ulvestad E, Becher B, Antel JP (1995): IL-10 production by adult human-derived microgial cells: IL-10 as a microglial autocrine cytokine. Neurochem Int (in press).
49. Wilt SG, Milward E, Zhou JM, Nagasato K, Patton H, Rusten R, Griffin DE, O'Connor M, Dubois-Dalcq M (1995): In vitro evidence for a dual role of tumor necrosis factor-α in human deficiency virus type I encephalopathy. Ann Neurol 37:381-394.
50. Wing MG, Zajicek JP, Seilly DJ, Compston DAS, Lachmann PJ (1992): Oligodendrocytes lack glycolipid anchored proteins which protect them against complement lysis. Restoration of resistance to lysis by incorporation of CD59. Immunology 76: 140-145.
51. Yong VW, Antel JP (1992): Culture of glial cells from human brain biopsies. In Federoff S, Richardson A (eds): "Protocols for Neural Cell Culture." Clifton, NJ: Humana Press, pp 76-81.
52. Zajicek JP, Wing M, Lachmann PJ, Compston DA (1992): Mechanisms of oligodendrocyte interaction with normal human serum - defining the role of complement. J Neurol Sci 108(1): 65-72.